3.Tezacaftor, Ivacaftor- (SYMEDEKO)- (Feb 2018)- to cystic fibrosis
Drug Name:
3.Tezacaftor, Ivacaftor- (SYMEDEKO)- (Feb 2018)- to cystic fibrosis
List Of Brands:
Indication Type Description:
Indication:
U.S. FDA APPROVED DRUGS DURING 2018
Sr.No- 3
Name of the Drug- SYMDEKO
Active Ingredient - Tezacaftor, Ivacaftor
Pharmacological Classification-
To treat cystic fibrosis in patients age 12 7ears and older
Date of Approval- 2-7-2018
(Ref- FDA approved List 2018)